Mark Smeltzer
Concepts (371)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 70 | 2024 | 326 | 14.780 |
Why?
| Bacterial Proteins | 42 | 2024 | 376 | 10.450 |
Why?
| Biofilms | 51 | 2024 | 181 | 10.420 |
Why?
| Staphylococcal Infections | 39 | 2024 | 268 | 8.670 |
Why?
| Osteomyelitis | 20 | 2024 | 126 | 6.070 |
Why?
| Gene Expression Regulation, Bacterial | 32 | 2024 | 191 | 5.890 |
Why?
| Trans-Activators | 20 | 2021 | 134 | 5.850 |
Why?
| Anti-Bacterial Agents | 32 | 2023 | 744 | 4.790 |
Why?
| Peptide Hydrolases | 11 | 2024 | 62 | 4.730 |
Why?
| Virulence Factors | 11 | 2024 | 78 | 3.700 |
Why?
| Mutation | 26 | 2023 | 1294 | 2.630 |
Why?
| Virulence | 16 | 2024 | 173 | 2.410 |
Why?
| Daptomycin | 10 | 2016 | 29 | 2.300 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 7 | 2018 | 76 | 1.940 |
Why?
| Protein Kinases | 4 | 2019 | 71 | 1.640 |
Why?
| Chitosan | 8 | 2021 | 34 | 1.450 |
Why?
| Disease Models, Animal | 21 | 2024 | 1455 | 1.420 |
Why?
| Animals | 47 | 2024 | 13187 | 1.370 |
Why?
| Mice | 34 | 2024 | 5739 | 1.320 |
Why?
| Metalloendopeptidases | 4 | 2024 | 70 | 1.300 |
Why?
| Polymethyl Methacrylate | 5 | 2019 | 26 | 1.290 |
Why?
| Phenotype | 8 | 2021 | 729 | 1.230 |
Why?
| Microbial Sensitivity Tests | 16 | 2023 | 269 | 1.130 |
Why?
| Xylitol | 3 | 2012 | 7 | 1.030 |
Why?
| Vancomycin | 13 | 2021 | 81 | 1.030 |
Why?
| Endopeptidases | 2 | 2023 | 66 | 0.970 |
Why?
| Gold | 5 | 2018 | 136 | 0.970 |
Why?
| Catheter-Related Infections | 9 | 2016 | 49 | 0.960 |
Why?
| Prosthesis-Related Infections | 4 | 2019 | 104 | 0.930 |
Why?
| Drug Delivery Systems | 4 | 2021 | 138 | 0.910 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 181 | 0.860 |
Why?
| Bacteremia | 4 | 2017 | 90 | 0.860 |
Why?
| Bacterial Infections | 3 | 2018 | 95 | 0.860 |
Why?
| Bacterial Toxins | 5 | 2020 | 52 | 0.840 |
Why?
| Nanoparticles | 3 | 2022 | 145 | 0.830 |
Why?
| Nanostructures | 2 | 2016 | 47 | 0.780 |
Why?
| Proteomics | 3 | 2019 | 329 | 0.770 |
Why?
| Repressor Proteins | 2 | 2021 | 151 | 0.750 |
Why?
| Bone Regeneration | 1 | 2021 | 68 | 0.740 |
Why?
| Drug Carriers | 6 | 2017 | 67 | 0.690 |
Why?
| Rabbits | 8 | 2021 | 370 | 0.630 |
Why?
| Deoxyribonucleases | 3 | 2015 | 23 | 0.620 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2012 | 192 | 0.620 |
Why?
| Humans | 47 | 2024 | 49974 | 0.620 |
Why?
| Communicable Diseases | 1 | 2018 | 55 | 0.580 |
Why?
| Proteome | 1 | 2018 | 173 | 0.560 |
Why?
| Sigma Factor | 2 | 2016 | 22 | 0.560 |
Why?
| Enterotoxins | 1 | 2016 | 12 | 0.560 |
Why?
| Recombinases | 1 | 2016 | 9 | 0.540 |
Why?
| Peptides, Cyclic | 1 | 2016 | 41 | 0.540 |
Why?
| Hemolysin Proteins | 3 | 2011 | 15 | 0.530 |
Why?
| Cephalosporins | 1 | 2016 | 41 | 0.520 |
Why?
| Serine Endopeptidases | 2 | 2014 | 52 | 0.520 |
Why?
| Host-Pathogen Interactions | 2 | 2016 | 134 | 0.520 |
Why?
| Extracellular Space | 4 | 2021 | 38 | 0.510 |
Why?
| Genetic Loci | 1 | 2015 | 49 | 0.500 |
Why?
| Transcription Factors | 5 | 2015 | 561 | 0.480 |
Why?
| Cysteine Endopeptidases | 1 | 2014 | 67 | 0.480 |
Why?
| Coated Materials, Biocompatible | 5 | 2022 | 33 | 0.470 |
Why?
| Amikacin | 4 | 2018 | 19 | 0.470 |
Why?
| Adhesins, Bacterial | 5 | 2012 | 27 | 0.460 |
Why?
| Delayed-Action Preparations | 2 | 2016 | 47 | 0.450 |
Why?
| Osteoclasts | 3 | 2024 | 425 | 0.450 |
Why?
| Plant Extracts | 2 | 2012 | 190 | 0.440 |
Why?
| RNA, Bacterial | 7 | 2011 | 58 | 0.440 |
Why?
| Hyaluronoglucosaminidase | 1 | 2013 | 6 | 0.440 |
Why?
| Gene Expression Profiling | 4 | 2009 | 1032 | 0.440 |
Why?
| Quercus | 1 | 2012 | 8 | 0.430 |
Why?
| Radius | 1 | 2012 | 28 | 0.410 |
Why?
| Ellagic Acid | 1 | 2012 | 6 | 0.410 |
Why?
| Rosaceae | 1 | 2012 | 9 | 0.410 |
Why?
| Osteoblasts | 3 | 2020 | 450 | 0.400 |
Why?
| Surgical Wound Infection | 1 | 2012 | 115 | 0.390 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 209 | 0.380 |
Why?
| Musculoskeletal Diseases | 2 | 2019 | 46 | 0.370 |
Why?
| Pseudomonas aeruginosa | 5 | 2019 | 72 | 0.370 |
Why?
| DNA, Bacterial | 4 | 2009 | 187 | 0.370 |
Why?
| RNA-Binding Proteins | 2 | 2012 | 123 | 0.370 |
Why?
| Mice, Inbred C57BL | 5 | 2020 | 1816 | 0.370 |
Why?
| Epistasis, Genetic | 1 | 2010 | 29 | 0.360 |
Why?
| Bone Cements | 3 | 2019 | 31 | 0.350 |
Why?
| Operon | 3 | 2016 | 29 | 0.350 |
Why?
| Bone Resorption | 2 | 2024 | 304 | 0.340 |
Why?
| Durapatite | 2 | 2021 | 24 | 0.320 |
Why?
| Positron-Emission Tomography | 2 | 2012 | 295 | 0.320 |
Why?
| RNA, Messenger | 6 | 2011 | 1105 | 0.320 |
Why?
| Genome, Bacterial | 2 | 2009 | 125 | 0.310 |
Why?
| DNA-Binding Proteins | 3 | 2009 | 427 | 0.300 |
Why?
| Rifampin | 2 | 2018 | 62 | 0.300 |
Why?
| Mutagenesis | 1 | 2007 | 60 | 0.290 |
Why?
| Gentamicins | 2 | 2021 | 31 | 0.280 |
Why?
| Arthritis, Infectious | 2 | 2006 | 44 | 0.270 |
Why?
| Glycine | 1 | 2006 | 75 | 0.270 |
Why?
| Joint Prosthesis | 1 | 2005 | 12 | 0.260 |
Why?
| Nanotechnology | 1 | 2005 | 35 | 0.260 |
Why?
| Titanium | 2 | 2022 | 48 | 0.260 |
Why?
| Genomics | 2 | 2021 | 286 | 0.260 |
Why?
| Phototherapy | 1 | 2005 | 45 | 0.260 |
Why?
| Polyethylene Glycols | 4 | 2021 | 93 | 0.250 |
Why?
| Methicillin | 1 | 2024 | 11 | 0.240 |
Why?
| DNA Transposable Elements | 2 | 2021 | 107 | 0.240 |
Why?
| Mammals | 1 | 2024 | 56 | 0.230 |
Why?
| Inflammation | 3 | 2013 | 604 | 0.230 |
Why?
| RANK Ligand | 1 | 2024 | 179 | 0.220 |
Why?
| Genes, Bacterial | 4 | 2009 | 64 | 0.210 |
Why?
| Micrococcal Nuclease | 3 | 2011 | 7 | 0.200 |
Why?
| Female | 8 | 2021 | 26472 | 0.200 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 63 | 0.200 |
Why?
| Research Design | 1 | 2023 | 344 | 0.200 |
Why?
| Catheters | 3 | 2016 | 31 | 0.190 |
Why?
| X-Ray Microtomography | 1 | 2021 | 77 | 0.190 |
Why?
| Debridement | 3 | 2015 | 46 | 0.190 |
Why?
| Tissue Scaffolds | 1 | 2021 | 33 | 0.190 |
Why?
| Biocompatible Materials | 2 | 2021 | 69 | 0.190 |
Why?
| Disease Susceptibility | 1 | 2021 | 89 | 0.190 |
Why?
| Chronic Disease | 2 | 2014 | 567 | 0.190 |
Why?
| Bacterial Adhesion | 4 | 2009 | 15 | 0.190 |
Why?
| Polymerase Chain Reaction | 1 | 2021 | 453 | 0.180 |
Why?
| Postoperative Complications | 2 | 2013 | 984 | 0.180 |
Why?
| Calcium Sulfate | 2 | 2014 | 7 | 0.170 |
Why?
| Osteochondrosis | 1 | 2019 | 7 | 0.170 |
Why?
| Bone and Bones | 2 | 2021 | 469 | 0.170 |
Why?
| Leukocidins | 1 | 2019 | 6 | 0.170 |
Why?
| Exotoxins | 1 | 2019 | 7 | 0.170 |
Why?
| Anti-Infective Agents | 2 | 2011 | 95 | 0.170 |
Why?
| Ciprofloxacin | 2 | 2018 | 21 | 0.170 |
Why?
| RNA, Double-Stranded | 1 | 2019 | 21 | 0.170 |
Why?
| Poultry Diseases | 1 | 2019 | 24 | 0.170 |
Why?
| RNA Stability | 2 | 2012 | 24 | 0.170 |
Why?
| Phagosomes | 1 | 2019 | 19 | 0.170 |
Why?
| Prostheses and Implants | 2 | 2019 | 54 | 0.170 |
Why?
| Protease Inhibitors | 2 | 2010 | 58 | 0.170 |
Why?
| Muscle, Skeletal | 1 | 2005 | 750 | 0.170 |
Why?
| Temperature | 2 | 2013 | 168 | 0.170 |
Why?
| Macrophages, Alveolar | 1 | 2019 | 28 | 0.170 |
Why?
| Sepsis | 1 | 2021 | 220 | 0.160 |
Why?
| Polysaccharides, Bacterial | 2 | 2010 | 13 | 0.160 |
Why?
| Colony Count, Microbial | 4 | 2011 | 66 | 0.160 |
Why?
| Genotype | 1 | 2020 | 537 | 0.160 |
Why?
| Osteogenesis | 1 | 2021 | 352 | 0.160 |
Why?
| Biopolymers | 1 | 2018 | 14 | 0.160 |
Why?
| Coinfection | 1 | 2018 | 38 | 0.150 |
Why?
| Clarithromycin | 1 | 2017 | 38 | 0.150 |
Why?
| Gram-Negative Bacteria | 1 | 2017 | 34 | 0.150 |
Why?
| Phosphatidylcholines | 1 | 2017 | 25 | 0.150 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2017 | 15 | 0.150 |
Why?
| Lipopeptides | 1 | 2017 | 63 | 0.150 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 236 | 0.140 |
Why?
| Teicoplanin | 1 | 2016 | 4 | 0.140 |
Why?
| Glycopeptides | 1 | 2016 | 10 | 0.140 |
Why?
| Aminoglycosides | 1 | 2016 | 18 | 0.140 |
Why?
| Materials Testing | 2 | 2014 | 58 | 0.140 |
Why?
| Catheterization | 2 | 2009 | 96 | 0.140 |
Why?
| Drug Evaluation, Preclinical | 1 | 2016 | 144 | 0.130 |
Why?
| Base Sequence | 4 | 2021 | 643 | 0.130 |
Why?
| Drug Resistance, Bacterial | 1 | 2016 | 71 | 0.130 |
Why?
| Photoacoustic Techniques | 2 | 2013 | 72 | 0.130 |
Why?
| Male | 8 | 2014 | 25241 | 0.130 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 40 | 0.130 |
Why?
| Adaptation, Physiological | 2 | 2006 | 91 | 0.130 |
Why?
| Microscopy, Confocal | 2 | 2012 | 88 | 0.120 |
Why?
| Amphotericin B | 1 | 2014 | 110 | 0.120 |
Why?
| Ultrasonics | 2 | 2005 | 29 | 0.120 |
Why?
| Methicillin Resistance | 2 | 2011 | 17 | 0.120 |
Why?
| Skin | 3 | 2016 | 409 | 0.120 |
Why?
| Pilot Projects | 1 | 2016 | 699 | 0.120 |
Why?
| RNA, Antisense | 2 | 2004 | 6 | 0.110 |
Why?
| Antineoplastic Agents | 1 | 2022 | 1171 | 0.110 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 32 | 0.110 |
Why?
| Transcription, Genetic | 3 | 2004 | 369 | 0.110 |
Why?
| Plant Stems | 1 | 2012 | 11 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 595 | 0.110 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 11 | 0.110 |
Why?
| Plant Leaves | 1 | 2012 | 43 | 0.110 |
Why?
| Meningoencephalitis | 1 | 2012 | 6 | 0.110 |
Why?
| Staphylococcus epidermidis | 1 | 2012 | 12 | 0.100 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 21 | 0.100 |
Why?
| Neoplastic Cells, Circulating | 1 | 2013 | 74 | 0.100 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2012 | 21 | 0.100 |
Why?
| Electrophoretic Mobility Shift Assay | 3 | 2012 | 73 | 0.100 |
Why?
| Carotenoids | 1 | 2012 | 49 | 0.100 |
Why?
| Cell Line | 2 | 2012 | 1000 | 0.100 |
Why?
| Chemical Fractionation | 1 | 2012 | 17 | 0.100 |
Why?
| Antifungal Agents | 1 | 2014 | 339 | 0.100 |
Why?
| Bone Remodeling | 1 | 2013 | 150 | 0.100 |
Why?
| Neoplasms | 1 | 2022 | 1235 | 0.100 |
Why?
| Biological Assay | 1 | 2012 | 45 | 0.100 |
Why?
| Glycosylation | 1 | 2012 | 100 | 0.100 |
Why?
| Promoter Regions, Genetic | 2 | 2004 | 475 | 0.100 |
Why?
| Integrin alpha5beta1 | 1 | 2011 | 3 | 0.100 |
Why?
| Fruit | 1 | 2012 | 136 | 0.100 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 61 | 0.100 |
Why?
| Asteraceae | 1 | 2011 | 10 | 0.100 |
Why?
| Lactones | 1 | 2011 | 26 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 224 | 0.100 |
Why?
| Ribonuclease P | 1 | 2011 | 3 | 0.100 |
Why?
| Wound Infection | 1 | 2011 | 27 | 0.100 |
Why?
| Staphylococcus | 2 | 2019 | 35 | 0.100 |
Why?
| Cell Death | 1 | 2012 | 181 | 0.100 |
Why?
| Mast Cells | 1 | 2011 | 52 | 0.090 |
Why?
| Tobramycin | 2 | 2019 | 15 | 0.090 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 24 | 0.090 |
Why?
| Blotting, Western | 1 | 2012 | 601 | 0.090 |
Why?
| Chromatography, Liquid | 1 | 2012 | 232 | 0.090 |
Why?
| Orthopedic Fixation Devices | 1 | 2010 | 3 | 0.090 |
Why?
| Flow Cytometry | 1 | 2013 | 476 | 0.090 |
Why?
| Mass Spectrometry | 1 | 2012 | 306 | 0.090 |
Why?
| Sesquiterpenes | 1 | 2011 | 90 | 0.090 |
Why?
| Models, Animal | 1 | 2011 | 233 | 0.090 |
Why?
| Inflammasomes | 2 | 2022 | 58 | 0.090 |
Why?
| Hemolysis | 2 | 2017 | 27 | 0.090 |
Why?
| Lasers | 2 | 2012 | 123 | 0.090 |
Why?
| Bacteriophage lambda | 1 | 2009 | 4 | 0.090 |
Why?
| Genetic Variation | 1 | 2011 | 213 | 0.090 |
Why?
| Integrases | 1 | 2009 | 43 | 0.090 |
Why?
| Phenols | 1 | 2011 | 113 | 0.090 |
Why?
| Wound Healing | 1 | 2011 | 204 | 0.090 |
Why?
| Hot Temperature | 2 | 2012 | 207 | 0.090 |
Why?
| Plankton | 2 | 2011 | 5 | 0.090 |
Why?
| Femur | 2 | 2024 | 133 | 0.080 |
Why?
| Acetoin | 1 | 2008 | 2 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 411 | 0.080 |
Why?
| Acute Disease | 1 | 2010 | 366 | 0.080 |
Why?
| Chemistry, Pharmaceutical | 1 | 2008 | 32 | 0.080 |
Why?
| Butylene Glycols | 1 | 2008 | 14 | 0.080 |
Why?
| Genetic Complementation Test | 1 | 2008 | 47 | 0.080 |
Why?
| Hydrogen-Ion Concentration | 2 | 2009 | 175 | 0.080 |
Why?
| Brain | 2 | 2013 | 1328 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1376 | 0.080 |
Why?
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2007 | 1 | 0.070 |
Why?
| Bacteriological Techniques | 1 | 2007 | 41 | 0.070 |
Why?
| Regulon | 1 | 2006 | 8 | 0.070 |
Why?
| Microspheres | 1 | 2006 | 25 | 0.070 |
Why?
| Cell Survival | 1 | 2008 | 600 | 0.070 |
Why?
| Permeability | 1 | 2006 | 68 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2018 | 349 | 0.070 |
Why?
| Soft Tissue Infections | 1 | 2006 | 8 | 0.070 |
Why?
| Microscopy, Phase-Contrast | 1 | 2005 | 11 | 0.070 |
Why?
| Surface Plasmon Resonance | 1 | 2005 | 22 | 0.070 |
Why?
| Spectrophotometry | 1 | 2005 | 33 | 0.070 |
Why?
| Binding Sites | 2 | 2004 | 374 | 0.070 |
Why?
| DNA | 1 | 2009 | 541 | 0.070 |
Why?
| Matrix Metalloproteinases | 1 | 2006 | 48 | 0.070 |
Why?
| Arginine | 1 | 2007 | 179 | 0.070 |
Why?
| Microscopy, Electron, Transmission | 1 | 2005 | 75 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2005 | 77 | 0.070 |
Why?
| Microscopy | 1 | 2005 | 56 | 0.060 |
Why?
| Gene Deletion | 1 | 2006 | 266 | 0.060 |
Why?
| Spectrum Analysis, Raman | 1 | 2005 | 58 | 0.060 |
Why?
| Osteonecrosis | 1 | 2005 | 34 | 0.060 |
Why?
| Protein Transport | 1 | 2005 | 180 | 0.060 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 54 | 0.060 |
Why?
| Cytokines | 2 | 2022 | 612 | 0.060 |
Why?
| Antigens, Bacterial | 1 | 2005 | 54 | 0.060 |
Why?
| Anaerobiosis | 1 | 2004 | 18 | 0.060 |
Why?
| Phylogeny | 1 | 2005 | 235 | 0.060 |
Why?
| Consensus Sequence | 1 | 2003 | 24 | 0.060 |
Why?
| Fibroblasts | 1 | 2006 | 345 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 304 | 0.060 |
Why?
| Enhancer Elements, Genetic | 1 | 2003 | 61 | 0.060 |
Why?
| Time Factors | 2 | 2009 | 2903 | 0.050 |
Why?
| Friction | 1 | 2022 | 3 | 0.050 |
Why?
| Oligonucleotides | 1 | 2003 | 80 | 0.050 |
Why?
| Down-Regulation | 1 | 2004 | 348 | 0.050 |
Why?
| Ligands | 1 | 2003 | 204 | 0.050 |
Why?
| Burkholderia | 1 | 2002 | 11 | 0.050 |
Why?
| Surface Properties | 1 | 2022 | 72 | 0.050 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 225 | 0.050 |
Why?
| Molecular Imaging | 2 | 2013 | 53 | 0.050 |
Why?
| Up-Regulation | 1 | 2004 | 452 | 0.050 |
Why?
| Lipase | 1 | 2002 | 13 | 0.050 |
Why?
| Knee Prosthesis | 1 | 2002 | 49 | 0.050 |
Why?
| Fibronectins | 1 | 2002 | 39 | 0.050 |
Why?
| Genes, Essential | 1 | 2021 | 11 | 0.050 |
Why?
| Mutagenesis, Insertional | 1 | 2021 | 24 | 0.050 |
Why?
| Diagnosis, Differential | 1 | 2005 | 1037 | 0.050 |
Why?
| Gene Library | 1 | 2021 | 43 | 0.050 |
Why?
| Hip Prosthesis | 1 | 2002 | 71 | 0.050 |
Why?
| Child | 2 | 2013 | 6847 | 0.050 |
Why?
| Mannitol | 1 | 2021 | 14 | 0.050 |
Why?
| Collagen | 1 | 2002 | 206 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 169 | 0.040 |
Why?
| Carrier Proteins | 1 | 2002 | 304 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2022 | 322 | 0.040 |
Why?
| Incidence | 1 | 2003 | 1003 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2003 | 945 | 0.040 |
Why?
| Models, Molecular | 2 | 2011 | 338 | 0.040 |
Why?
| Necrosis | 1 | 2019 | 176 | 0.040 |
Why?
| Protein Binding | 2 | 2012 | 660 | 0.040 |
Why?
| Chickens | 1 | 2019 | 107 | 0.040 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2002 | 261 | 0.040 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2002 | 282 | 0.040 |
Why?
| Paenibacillus | 1 | 2017 | 6 | 0.040 |
Why?
| Rats | 2 | 2015 | 3305 | 0.040 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2017 | 39 | 0.040 |
Why?
| Drug Synergism | 1 | 2017 | 150 | 0.040 |
Why?
| Drug Combinations | 1 | 2017 | 123 | 0.040 |
Why?
| Analysis of Variance | 1 | 2018 | 562 | 0.030 |
Why?
| Structure-Activity Relationship | 1 | 2017 | 395 | 0.030 |
Why?
| Freeze Drying | 1 | 2016 | 7 | 0.030 |
Why?
| Drug Compounding | 1 | 2016 | 24 | 0.030 |
Why?
| Polytetrafluoroethylene | 1 | 2016 | 32 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2009 | 792 | 0.030 |
Why?
| Acetates | 1 | 2016 | 49 | 0.030 |
Why?
| Lung | 1 | 2019 | 486 | 0.030 |
Why?
| Porifera | 1 | 2014 | 2 | 0.030 |
Why?
| Musculoskeletal System | 1 | 2014 | 16 | 0.030 |
Why?
| Point-of-Care Systems | 1 | 2015 | 56 | 0.030 |
Why?
| Cerebral Ventricles | 1 | 2013 | 28 | 0.030 |
Why?
| Phosphorylation | 1 | 2015 | 535 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2014 | 99 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 35 | 0.030 |
Why?
| Spectrum Analysis | 1 | 2013 | 70 | 0.030 |
Why?
| Staining and Labeling | 1 | 2013 | 97 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 9 | 0.030 |
Why?
| Equipment Design | 1 | 2014 | 284 | 0.030 |
Why?
| Color | 1 | 2012 | 22 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.030 |
Why?
| Lipoproteins | 1 | 2012 | 39 | 0.030 |
Why?
| Light | 1 | 2012 | 71 | 0.030 |
Why?
| Antibodies | 1 | 2012 | 154 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 49 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 252 | 0.030 |
Why?
| Plant Components, Aerial | 1 | 2011 | 4 | 0.020 |
Why?
| Disease Reservoirs | 1 | 2011 | 4 | 0.020 |
Why?
| Carrier State | 1 | 2011 | 9 | 0.020 |
Why?
| Immune Evasion | 1 | 2011 | 11 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2011 | 76 | 0.020 |
Why?
| Cytotoxicity, Immunologic | 1 | 2011 | 54 | 0.020 |
Why?
| Hep G2 Cells | 1 | 2011 | 36 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2011 | 147 | 0.020 |
Why?
| Endocytosis | 1 | 2011 | 57 | 0.020 |
Why?
| Tensile Strength | 1 | 2010 | 28 | 0.020 |
Why?
| Molecular Structure | 1 | 2011 | 297 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2011 | 244 | 0.020 |
Why?
| Small Molecule Libraries | 1 | 2011 | 68 | 0.020 |
Why?
| Attachment Sites, Microbiological | 1 | 2009 | 3 | 0.020 |
Why?
| Sequence Alignment | 1 | 2009 | 121 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 388 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2009 | 96 | 0.020 |
Why?
| Deoxyribonuclease I | 1 | 2009 | 34 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 253 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2013 | 1403 | 0.020 |
Why?
| Plasmids | 1 | 2009 | 161 | 0.020 |
Why?
| Databases, Genetic | 1 | 2009 | 88 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2009 | 322 | 0.020 |
Why?
| Escherichia coli | 1 | 2009 | 186 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2009 | 585 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 973 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 1159 | 0.020 |
Why?
| Models, Biological | 1 | 2011 | 727 | 0.020 |
Why?
| Species Specificity | 1 | 2007 | 192 | 0.020 |
Why?
| Synovial Membrane | 1 | 2006 | 17 | 0.020 |
Why?
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 11 | 0.020 |
Why?
| Half-Life | 1 | 2006 | 84 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 33 | 0.020 |
Why?
| Apoptosis | 1 | 2011 | 1101 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 244 | 0.020 |
Why?
| Osteoarthritis | 1 | 2006 | 62 | 0.020 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 105 | 0.020 |
Why?
| Ethidium | 1 | 2004 | 6 | 0.020 |
Why?
| Gene Expression | 1 | 2006 | 609 | 0.010 |
Why?
| Filtration | 1 | 2002 | 24 | 0.010 |
Why?
| Drug Implants | 1 | 2002 | 35 | 0.010 |
Why?
| Cells, Cultured | 1 | 2006 | 1573 | 0.010 |
Why?
| Prospective Studies | 1 | 2002 | 2364 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2002 | 3129 | 0.010 |
Why?
| Aged | 1 | 2002 | 9310 | 0.010 |
Why?
| Middle Aged | 1 | 2002 | 12069 | 0.000 |
Why?
| Adult | 1 | 2002 | 13236 | 0.000 |
Why?
|
|
Smeltzer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|